Psilocybin, a chemical compound derived from mushrooms, has been a topic of interest for researchers focused on neuropsychiatric conditions, specifically substance use disorders. A double-blind,...
The Bill and Melinda Gates Foundation recently granted $625,803 to Celanese — a chemical company focused on chemical intermediates, engineered materials, polymers, emulsions, and specialty food ingredients — to research and...
Glucocorticoids are widely prescribed for those struggling with autoimmune and neurological conditions and are considered one of the most prescribed drugs. In a study published in BMJ Open, researchers...
The overturning of Roe v. Wade in the 2022 Dobbs v. Jackson Women’s Health Organization United State Supreme Court case has brought about a lot of conversation about reproductive rights, including in vitro fertilization (IVF). The...
The only male forms of birth control currently available are condoms and vasectomies. With a limited choice in male birth control, contraception typically falls on the child-bearing individual. This...
While the general public may feel we are post-pandemic, healthcare workers know that COVID still runs rampant worldwide, especially in hospital settings. The recent study published in JAMA Network Open...
A recent statement by Verve Therapeutics announced the start of the phase 1b clinical trial on heterozygous familial hypercholesterolemia (HeFH) in New Zealand. This announcement highlighted the first...
At the end of June, Decibel Therapeutics announced success in the phase 1b clinical trials on DB-020 for cancer patients receiving cisplatin chemotherapy. DB-020 is a sodium thiosulfate (STS) drug...
The HPV vaccine rates have increased in adolescents. Between 2015 and 2020, the rate of HPV vaccination in juveniles expanded by 19.3%. This study looked at data from the National Immunization Surveys...
The Journal of the American Medical Association recently published an updated recommendation from the USTPF on using vitamins and supplements to prevent cardiovascular disease and cancer. The study...
On Tuesday, the CDC warned Americans about the potential for coronavirus recurrence after using Pfizer’s antiviral drug Paxlovid. CDC officials are not recommending any changes to the ordinary...
Bristol Myers Squibb and Nektar Therapeutics recently ended the global clinical development program for their combination drug therapy, bempegaldesleukin (BEMPEG) and Opdivo (nivolumab), in renal cell...
Novartis recently announced that its IgG4 anti-PD-1 monoclonal antibody, tislelizumab, plus chemotherapy, significantly improved overall survival (OS) compared to chemotherapy in esophageal...
GSK recently entered into a $1.9 billion agreement to acquire biopharmaceutical company Sierra Oncology to treat rare cancers.
Myelofibrosis is a rare blood cancer that causes considerable...
Roche recently announced that its monoclonal IgG1 antibody, tiragolumab, plus Tecentriq and chemotherapy, did not meet its co-primary endpoints in a Phase 3 extensive-stage small cell lung cancer...
Pfizer recently announced positive top-line results from a second Phase 3 study of its selective sphingosine 1-phosphate (S1P) receptor modulator, etrasimod, to treat moderately to severely active...
FDA recently amended the emergency use authorization of Moderna's COVID-19 vaccine to allow for a second booster dose at the 50 microgram level in adults 50 years of age and older.
The...
Thermo Fisher Scientific will invest $97 million to expand its clinical research operations in Virginia to support the increasing demand for drug development.
Over the next three years,...
Merck and the European Thoracic Oncology Platform (ETOP) recently announced that Keytruda significantly improved disease-free survival (DFS) in patients with stage IB to IIA non-small cell lung cancer...
AstraZeneca recently launched a global research and development Postdoctoral Challenge to help advance drug discovery for some of the world’s most complex diseases.
The challenge invites...
